Stay updated on Belantamab Mafodotin Combo in Relapsed MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin Combo in Relapsed MM Clinical Trial page.

Latest updates to the Belantamab Mafodotin Combo in Relapsed MM Clinical Trial page
- Check5 days agoChange DetectedThe Study Record Versions now include a new revision entry v3.5.4, replacing the previous v3.5.3 in the history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s displayed platform/release revision was updated from **Revision: v3.5.2** to **Revision: v3.5.3**. This reflects a maintenance or release update rather than a change to the trial’s published information.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded revision v3.5.2 and deleted revision v3.5.0 in the study history.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision history updated to include a new entry v3.5.0 and remove v3.4.3 from the study record versions.SummaryDifference0.1%

- Check70 days agoChange DetectedThe history now shows Revision: v3.4.3 added and Revision: v3.4.2 removed.SummaryDifference0.1%

- Check98 days agoChange DetectedAdded a new revision entry (v3.4.2) to the Record History. Removed the funding-notice banner and the older revision entry (v3.4.1), altering the visible historical record.SummaryDifference0.9%

Stay in the know with updates to Belantamab Mafodotin Combo in Relapsed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin Combo in Relapsed MM Clinical Trial page.